Clinical Trials in Los Angeles

Showing 9021-9040 of 14,465 trials

Evaluation of SC Injected Tc 99m Tilmanocept Localization in Active RA Subjects by SPECT and SPECT/CT Imaging

NCT02683421

Determine the localization of Tc 99m tilmanocept by SPECT and SPECT/CT imaging in subjects with active RA and concordance with clinical symptomology.

Rheumatoid Arthritis

Navidea Biopharmaceuticals18 participantsStarted Jul 2016

Los Angeles, California, United States • San Francisco, California, United States

COMPLETED< 1 mile

Lucica ® Glycated Albumin-L Clinical Program - Pivotal Study

NCT02489773

To confirm that Lucica ® Glycated Albumin-L is useful for the intermediate term (preceding 2-3 weeks) monitoring of glycemic control in patients with diabetes.

Diabetes

Asahi Kasei Therapeutics Corporation150 participantsStarted Jun 2015

Los Angeles, California, United States • Los Angeles, California, United States • Lexington, Kentucky, United States +5 more locations

TERMINATEDNA< 1 mile

CONTINuous Infra-Inguinal Stenting Using the Bard® LifeStent® VascUlar Stent SysteMs ("CONTINUUM")

NCT00908947

The objectives of this study are to collect post-market confirmatory evidence of the safety and effectiveness of the Bard® LifeStent® Vascular Stent System and LifeStent® XL Vascular Stent System (together the "LifeStent® Vascular Stent System").

Superficial Femoral Artery Stenosis

C. R. Bard173 participantsStarted Feb 2011

Los Angeles, California, United States • Pleasanton, California, United States • Fort Lauderdale, Florida, United States +26 more locations

Evaluation of SC Injected Tc 99m Tilmanocept Localization in Active RA Subjects by SPECT and SPECT/CT Imaging

Lucica ® Glycated Albumin-L Clinical Program - Pivotal Study

CONTINuous Infra-Inguinal Stenting Using the Bard® LifeStent® VascUlar Stent SysteMs ("CONTINUUM")

Find Trials by Condition in Los Angeles

POSITIVE Stroke Clinical Trial

Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY)

Evaluation of the Effect of Lurbinectedin (PM01183) on Cardiac Repolarization in Patients With Selected Solid Tumors

Macrolide Azithromycin to Prevent Rapid Worsening of Symptoms Associated With Chronic Obstructive Pulmonary Disease

Phase II Study of Folotyn With Leucovorin to Prevent/Reduce Mucositis in Patients With Hematological Malignancies

Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228

Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart Compared to NovoRapid® in Adults With Type 1 Diabetes

Safety of Intravenous Neridronic Acid in CRPS

Study of Debio 1450 for Bacterial Skin Infections

Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer

Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients

A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF)

A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis

Safety Study of ALRN-6924 in Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study

A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma

Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's Disease